首页> 外文期刊>Modern Pathology >Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients
【24h】

Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients

机译:卵巢浆液性癌患者中eIF6和Dicer表达的改变与临床病理特征相关

获取原文
           

摘要

MicroRNAs are a group of small non-coding RNAs approximately 22 nucleotides in length. Recent work has shown differential expression of mature microRNAs in human cancers. Production and function of microRNAs require coordinated processing by proteins of the microRNA machinery. Dicer and Drosha (RNase III endonucleases) are essential components of the microRNA machinery. Recently, the ribosome anti-association factor eIF6 has also been found to have a role in microRNA-mediated post-transcriptional silencing. We characterized the alterations in the expression of genes encoding proteins of microRNA machinery in ovarian serous carcinoma. Protein expression of eIF6 and Dicer was quantified in a tissue microarray of 66 ovarian serous carcinomas. Dicer, Drosha and eIF6 mRNA expression was analysed using quantitative reverse transcription-PCR on an independent set of 50 formalin-fixed, paraffin-embedded ovarian serous carcinoma samples. Expression profiles of eIF6 and Dicer were correlated with clinicopathological and patient survival data. We provide definitive evidence that eIF6 and Dicer are both upregulated in a significant proportion of ovarian serous carcinomas and are associated with specific clinicopathological features, most notably low eIF6 expression being associated with reduced disease-free survival. The status of eIF6 and proteins of the microRNA machinery may help predict toxicity and susceptibility to future interfering RNA-based therapy.
机译:MicroRNA是一组小的非编码RNA,长度约为22个核苷酸。最近的工作表明成熟的microRNA在人类癌症中的差异表达。 microRNA的产生和功能需要microRNA机制的蛋白质协调处理。 Dicer和Drosha(RNase III核酸内切酶)是microRNA机制的重要组成部分。最近,还发现核糖体抗缔合因子eIF6在microRNA介导的转录后沉默中起作用。我们表征了卵巢浆液性癌中编码microRNA机械蛋白的基因表达的变化。在66个卵巢浆液性癌的组织芯片中定量了eIF6和Dicer的蛋白表达。在独立的50个福尔马林固定,石蜡包埋的卵巢浆液性癌样本中,使用定量逆转录PCR对Dicer,Drosha和eIF6 mRNA的表达进行了分析。 eIF6和Dicer的表达谱与临床病理和患者生存数据相关。我们提供了明确的证据,eIF6和Dicer在相当大比例的卵巢浆液性癌中均被上调,并且与特定的临床病理特征有关,最显着的是eIF6的低表达与无病生存期降低有关。 eIF6和microRNA机制蛋白的状态可能有助于预测对未来基于RNA干扰的治疗的毒性和敏感性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号